Genetic Characterization of ABT-199 Sensitivity in Human AML
Sign Up to like & getrecommendations! Published in 2018 at "Blood"
DOI: 10.1182/blood-2018-99-113062
Abstract: Acute myeloid leukemias (AML) are aggressive blood cancers characterized by an overall survival of 27% at 5 years. The main challenge in AML treatment originates from the genetic heterogeneity of the disease that contributes to… read more here.
Keywords: treatment; abt 199; aml; 199 sensitivity ... See more keywords